Suchergebnisse - "Antineoplastic Agents"

PubPharm (16.358)

91

Investigating the Promising Anticancer Activity of Cetuximab and Fenbendazole Combination as Dual CBS and VEGFR-2 Inhibitors and Endowed with Apoptotic Potential

enthalten in: Chemistry & biodiversity | 2024

von Eid, N. | Al-Karmalawy, A. | Eldebss, T. | +1

92

L-Methionine accentuates anti-tumor action of Gefitinib in Gefitinib-resistant lung adenocarcinoma : Role of EGFR/ERK/AKT signaling and histone H3K36me2 alteration

enthalten in: Toxicology and applied pharmacology | 2024

von Pal, S. | Kabeer, S. | Tikoo, K.

93

New thiazolidine-2,4-diones as potential anticancer agents and apoptotic inducers targeting VEGFR-2 kinase : Design, synthesis, in silico and in vitro studies

enthalten in: Biochimica et biophysica acta. General subjects | 2024

von Elkady, H. | Mahdy, H. | Taghour, M. | +10

94

Tenovin 3 induces apoptosis and ferroptosis in EGFR 19del non small cell lung cancer cells

enthalten in: Scientific reports | 2024

von Lv, S. | Pan, Q. | Lu, W. | +10

95

Antitumor activity of extracellular signal-regulated kinases 1/2 inhibitor BVD-523 (ulixertinib) on thyroid cancer cells

enthalten in: Journal of cancer research and therapeutics | 2024

von Chen, Y. | Xiao, X. | Hu, G. | +2

96

Discovery of novel anaplastic lymphoma kinase (ALK) and histone deacetylase (HDAC) dual inhibitors exhibiting antiproliferative activity against non-small cell lung cancer

enthalten in: Journal of enzyme inhibition and medicinal chemistry | 2024

von Wang, K. | Yeh, T. | Hsu, P. | +5

97

Targeting the PI3K/AKT signaling pathway in anticancer research : a recent update on inhibitor design and clinical trials (2020-2023)

enthalten in: Expert opinion on therapeutic patents | 2024

von Sabbah, D. | Hajjo, R. | Bardaweel, S. | +1

98

Evidence-Based Recommendations for Education Provided to Patients and Families Regarding the Adverse Events of ALK and MEK Inhibitors : A Systematic Review From the Children's Oncology Group

enthalten in: Journal of pediatric hematology/oncology nursing | 2024

von Fisher, B. | Meyer, A. | Brown, A. | +5

99

Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials

enthalten in: Leukemia | 2024

von Jabbour, E. | Apperley, J. | Cortes, J. | +17

100

Exploring new quinazolin-4(3H)-one derivatives as CDK2 inhibitors : Design, synthesis, and anticancer evaluation

enthalten in: Drug development research | 2024

von Ibrahim, B. | Allam, H. | El-Dydamony, N. | +2